Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation

NCT02634697 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02634697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02634697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
January 9, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, atrial fibrillation, depression, hostility, quality of life, stress